Skip Navigation


Rheumatology Advance Access originally published online on May 20, 2009
Rheumatology 2009 48(7):862-863; doi:10.1093/rheumatology/kep123
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
48/7/862    most recent
kep123v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Alexandrescu, D. T.
Right arrow Articles by Dasanu, C. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alexandrescu, D. T.
Right arrow Articles by Dasanu, C. A.
Related Collections
Right arrow Crystal Arthritis
Right arrow Pharmacology
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Acute gout during treatment with paclitaxel for metastatic melanoma

Doru T. Alexandrescu1, Thomas E. Ichim2, Filamer Kabigting3 and Constantin A. Dasanu4

1Georgetown Dermatology, Washington, DC,2Medistem Inc., San Diego, CA,3Department of Medicine, Division of Dermatology, University of California at San Diego, La Jolla, CA and 4Department of Hematology-Oncology, Saint Francis Hospital and Medical Center, Hartford, CT, USA

Correspondence to: Doru T. Alexandrescu, Georgetown Dermatology, 140 Michigan Avenue NE T44, Washington, DC 20017, USA. E-mail: mddoru@hotmail.com

The first 10% of the full text of this article appears below.

SIR, Gout is caused by extracellular urate supersaturation and precipitation in the articular cartilages, tendons or surrounding tissues. Hyperuricaemia is associated with the treatment of fast-growing malignancies, particularly haematological neoplasms. We present a case of acute gout precipitated by the chemotherapeutic agent paclitaxel, used for the treatment of metastatic melanoma, which occurred in the absence of tumour lysis syndrome.

A 61-year-old male with metastatic melanoma and a longstanding mild idiopathic gout presented for a pulmonary metastatic relapse. His gout, of . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?